CONGRATS-combination of nivolumab plus relatlimab in patients with advanced or metastatic soft-tissue sarcoma: A proof-of-concept randomized phase II study

被引：1

作者：

Ceruso, M. Spalato ^{[1
]}

Albert, S. ^{[2
]}

Italiano, A. ^{[1
]}

Toulmonde, M. ^{[3
]}

Cousin, S. ^{[4
]}

Grellety, T. ^{[1
]}

Blay, J-Y. ^{[5
]}

Verret, B. ^{[6
]}

Auzanneau, C. ^{[7
]}

Valade, V.

Poignie, L.

Lortal, B. ^{[8
]}

Kind, M. ^{[9
]}

Le Loarer, F. ^{[10
]}

Pulido, M. ^{[2
]}

机构：

[1] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France

[2] Inst Bergonie, Clin & Rereach Unit, Bordeaux, France

[3] Ctr Reg Lutte Canc CLCC, Inst Bergonie, Med Oncol Dept, Bordeaux, France

[4] Inst Bergonie, Early Phase Trials, Bordeaux, France

[5] Ctr Leon Berard, Med Dept, Lyon, France

[6] Gustave Roussy, Med Oncol Dept, Villejuif, France

[7] Inst Bergonie, Biol & Pathol Unit, Bordeaux, France

[8] Inst Bergonie, Pharm, Bordeaux, France

[9] Inst Bergonie, Radiol Unit, Bordeaux, France

[10] Inst Bergonie, Pathol, Bordeaux, France

来源：

关键词：

D O I：

10.1016/j.annonc.2022.07.1916

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1527TiP

引用

页码：S1243 / S1243

页数：1